Publications found:
387
Sort by:
Dermatitis Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application
US$ 3,950.00
The Dermatitis Market is valued at USD 8.2 billion in 2025 and is projected to grow at a CAGR of 5.8% to reach USD 13.6 billion by 2034.The Dermatitis Market focuses on the diagnosis and treatment of...
October 2025
160 pages
Dermatology Otc Medications Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Tablets And Capsules, Oils Gels, Creams And Ointments, Other Types), By Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Anti-Fungal, Wart Remover, Other Indications), By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Dermatology Otc Medications Market is valued at USD 14.1 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 21.4 billion by 2034.The Dermatology OTC Medications Market encompa...
October 2025
160 pages
Exocrine Pancreatic Insufficiency (Epi) Therapeutics And Diagnostics Market Outlook 2025-2034: Market Share, and Growth Analysis By Therapies (Nutritional Management, Pancreatic Enzyme Replacement Therapy (PERT), Lifestyle Modifications Approach), By Diagnostics (Blood Tests, Magnetic Resonance Imaging (MRI), Endoscopic Ultra-Sonography (EUS), Computerized Tomography (CT) Scanning), By Drug Type, By Distribution Channel, By End User
US$ 3,950.00
The Exocrine Pancreatic Insufficiency (Epi) Therapeutics And Diagnostics Market is valued at USD 7.2 billion in 2025 and is projected to grow at a CAGR of 8.8% to reach USD 15.4 billion by 2034. Exocr...
October 2025
160 pages
Gastroesophageal Reflux Disease (Gerd) Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)), By Procedure (Invasive, Minimally Invasive), By End-Users
US$ 3,950.00
The Gastroesophageal Reflux Disease (Gerd) Market is valued at USD 6.2 billion in 2025 and is projected to grow at a CAGR of 1.7% to reach USD 7.2 billion by 2034. Gastroesophageal Reflux Disease (GER...
October 2025
160 pages
Gastroesophageal Reflux Disease Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Branded, Generic), By Drug Class (Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class), By Distribution Channel, By Application
US$ 3,950.00
The Gastroesophageal Reflux Disease Therapeutics Market is valued at USD 7.6 billion in 2025 and is projected to grow at a CAGR of 3.2% to reach USD 10.1 billion by 2034. Gastroesophageal Reflux Disea...
October 2025
160 pages
Gastroparesis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Over-the-counter (OTC) Drugs, Prescription Drugs), By Drug Class (Prokinetic Agents, Antiemetic Drugs, Proton Pump Inhibitors, Other Drug Classes), By Disease Type, By Route Of Administration, By Distribution Channel
US$ 3,950.00
The Gastroparesis Drugs Market is valued at USD 6.7 billion in 2025 and is projected to grow at a CAGR of 6.7% to reach USD 12 billion by 2034. Gastroparesis Drugs Market Overview The Gastroparesis Dr...
October 2025
160 pages
Gaucher’S Disease Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, Other Types), By Diagnosis (Physical Exam, Blood Tests, Imaging Tests, Preconception Screening and Prenatal Testing, Other Diagnoses), By Therapy, By Route Of Administration, By End User
US$ 3,950.00
The Gaucher’S Disease Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 6.5% to reach USD 3.7 billion by 2034. Gaucher’s Disease Market Overview The Gaucher’s Disease M...
October 2025
160 pages
Generic Musculoskeletal Disorders Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment Type (Medication, Therapy, Surgery, Other Treatment Types), By Disorder Type (Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types), By Route of Administration, By Distribution Channel
US$ 3,950.00
The Generic Musculoskeletal Disorders Drugs Market is valued at USD 83.1 million in 2025 and is projected to grow at a CAGR of 6.2% to reach USD 142.7 million by 2034. Generic Musculoskeletal Disorder...
October 2025
160 pages
Hepatitis Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Interferon Alphas, HIV NRTIs, Nucleotide Polymerase/NS5A Inhibitor Combinations, Hepatitis C Protease/NS5A Inhibitor Combinations, NS5A Inhibitors, Nucleotide Polymerase Inhibitors, Nucleoside Analogue Antivirals, Thrombopoiesis Stimulating Agents), By Route Of Administration (Oral, Injection), By Distribution Channel, By Application
US$ 3,950.00
The Hepatitis Drugs Market is valued at USD 18.5 billion in 2025 and is projected to grow at a CAGR of 5% to reach USD 28.7 billion by 2034.The Hepatitis Drugs Market is experiencing a transformative...
October 2025
160 pages
Herbal Medicine Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Capsules And Tablets, Powders, Extracts, Syrups, Other Products), By Category (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Dietary Supplements, Herbal Beauty Products), By Distribution Channel, By Application
US$ 3,950.00
The Herbal Medicine Market is valued at USD 195.6 billion in 2025 and is projected to grow at a CAGR of 11.2% to reach USD 508.9 billion by 2034.The global herbal medicine market has gained substantia...
October 2025
160 pages
Herpangina Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Topical Anesthetics, Ibuprofen Or Acetaminophen, Other Treatments), By Virus (Coxsackie Virus A, Coxsackie Virus B, Enterovirus 71, Echovirus), By Symptoms, By End User
US$ 3,950.00
The Herpangina Treatment Market is valued at USD 2.5 billion in 2025 and is projected to grow at a CAGR of 7.7% to reach USD 4.9 billion by 2034.The Herpangina Treatment Market is gaining significant...
October 2025
160 pages
Homeopathy Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, Other Types), By Source (Plants, Animals, Minerals), By Distribution Channel, By Application
US$ 3,950.00
The Homeopathy Market is valued at USD 12.2 billion in 2025 and is projected to grow at a CAGR of 15% to reach USD 43 billion by 2034.The global homeopathy market has grown steadily in recent years, d...
October 2025
160 pages
Immunosuppressants Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel
US$ 3,950.00
The Immunosuppressants Market is valued at USD 28.3 billion in 2025 and is projected to grow at a CAGR of 15.2% to reach USD 101 billion by 2034.The Immunosuppressants Market is critical to the treatm...
October 2025
160 pages
Irritable Bowel Syndrome (Ibs) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel, By End-Users
US$ 3,950.00
The Irritable Bowel Syndrome (Ibs) Treatment Market is valued at USD 3.8 billion in 2025 and is projected to grow at a CAGR of 10% to reach USD 9 billion by 2034.The Irritable Bowel Syndrome (IBS) Tre...
October 2025
160 pages
Janus Kinase (Jak) Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Inhibitors Type (Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, Other Inhibitor Types), By Mode Of Administration (Injectable, Oral, Other Modes Of Administration), By Distribution Channel, By Application
US$ 3,950.00
The Janus Kinase (Jak) Inhibitors Market is valued at USD 20.7 billion in 2025 and is projected to grow at a CAGR of 20.6% to reach USD 112 billion by 2034.The Janus Kinase (JAK) Inhibitors Market is...
October 2025
160 pages
Ketolides Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Type (Telithromycin, Cethromycin, Solithromycin), By Indication (Bronchitis, Pneumonia, Sinusitis, Tonsillitis Or Pharyngitis), By Microorganism, By Distribution Channel
US$ 3,950.00
The Ketolides Market is valued at USD 4.1 billion in 2025 and is projected to grow at a CAGR of 5.5% to reach USD 6.6 billion by 2034.The Ketolides Market comprises a class of antibiotics structurally...
October 2025
160 pages
Lysosomal Disease Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Disease Type (Mucopolysaccharidosis, Pompe Syndrome, Fabry Diseases, Gaucher's Disease, Other Disease Types), By Therapy (Substrate Reduction Therapy, Stem Cell Therapy, Enzyme Replacement Therapy, Other Therapies), By Route Of Administration, By End User
US$ 3,950.00
The Lysosomal Disease Treatment Market is valued at USD 8.8 billion in 2025 and is projected to grow at a CAGR of 7.4% to reach USD 16.7 billion by 2034.The lysosomal disease treatment market addresse...
October 2025
160 pages
Malaria Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments), By Route of Administration (Oral, Parenteral, Intravenous), By Distribution Channel, By End User
US$ 3,950.00
The Malaria Treatment Market is valued at USD 2 billion in 2025 and is projected to grow at a CAGR of 5.8% to reach USD 3.3 billion by 2034.The malaria treatment market encompasses a broad range of an...
October 2025
160 pages
Male Hypogonadism Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types), By Drug Delivery (Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries), By Therapy
US$ 3,950.00
The Male Hypogonadism Market is valued at USD 4.9 billion in 2025 and is projected to grow at a CAGR of 7.1% to reach USD 9.1 billion by 2034.The male hypogonadism market encompasses diagnostic tools...
October 2025
160 pages
Organ Transplant Immunosuppressant Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, Others Drug Classes), By Transplant Type (Heart, Kidney, Liver, Lung, Pancreas, Other Transplant Types), By Distribution Channel
US$ 3,950.00
The Organ Transplant Immunosuppressant Drugs Market is valued at USD 6.9 billion in 2025 and is projected to grow at a CAGR of 3.1% to reach USD 9.1 billion by 2034.The organ transplant immunosuppress...
October 2025
160 pages
Otc Drug And Dietary Supplement Market Outlook 2025-2034: Market Share, and Growth Analysis By Category (Vitamin And Dietary Supplements, Cough And Cold Products, Analgesics, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Other Categories), By Dosage Form (Tablets, Hard Capsules, Powders, Ointments, Soft Capsules, Liquids, Other Dosage Forms), By Application
US$ 3,950.00
The Otc Drug And Dietary Supplement Market is valued at USD 308 billion in 2025 and is projected to grow at a CAGR of 7% to reach USD 564.8 billion by 2034.The OTC drug and dietary supplement market h...
October 2025
160 pages
Over The Counter (Otc) Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Cough, Cold And Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral And Supplements (VMS), Weight Loss Or Dietary Products, Ophthalmic Products, Sleeping Aids, Other Product Types), By Formulation Type (Tablets, Liquids, Ointments, Sprays), By Distribution Channel, By End-Users
US$ 3,950.00
The Over The Counter (Otc) Drugs Market is valued at USD 133.9 billion in 2025 and is projected to grow at a CAGR of 5.8% to reach USD 222.4 billion by 2034.The over-the-counter (OTC) drug market is e...
October 2025
160 pages
Prescription To Over-The-Counter (Rx-To-Otc) Switches Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Allergy And Respiratory, Fungal Infections And Other Infections, Oral Contraceptive, Gastrointestinal Drugs, Other Products), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drug Stores, Online Pharmacies), By End-User
US$ 3,950.00
The Prescription To Over-The-Counter (Rx-To-Otc) Switches Market is valued at USD 40.8 billion in 2025 and is projected to grow at a CAGR of 8.4% to reach USD 84.5 billion by 2034.The Prescription to...
October 2025
160 pages
Quit Smoking Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets), By Drug (Varenicline (Chantix), Bupropion (Zyban), Other Drugs), By Distribution
US$ 3,950.00
The Quit Smoking Drugs Market is valued at USD 40.6 billion in 2025 and is projected to grow at a CAGR of 13.4% to reach USD 125.8 billion by 2034. Market Overview The quit smoking drugs market has se...
October 2025
160 pages
Seborrheic Dermatitis Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Anti-Inflammatory, Antifungal, Corticosteroid Lotions, Sulfur Products, Other Treatments), By Diagnosis (Physical Examination, Biopsy, Other Diagnoses), By Dosage Form, By Route Of Administration, By End-Users
US$ 3,950.00
The Seborrheic Dermatitis Market is valued at USD 3.7 billion in 2025 and is projected to grow at a CAGR of 12.6% to reach USD 10.8 billion by 2034.The seborrheic dermatitis market encompasses a range...
October 2025
160 pages
Testosterone Replacement Therapy Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Oral, Implants, Gel Or Creams, Patches, Buccal Adhesive, Parenteral, Other Products), By Indication (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, Other Indications), By Active Ingredient Type, By End User
US$ 3,950.00
The Testosterone Replacement Therapy Market is valued at USD 2.5 billion in 2025 and is projected to grow at a CAGR of 3.1% to reach USD 3.3 billion by 2034.The Testosterone Replacement Therapy (TRT)...
October 2025
160 pages
Tnf Alpha Inhibitors Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Remicade (Infliximab), Enbrel (Etanercept), Humira (Adalimumab), Cimzia (Certolizumab Pegol), Simponi (Golimumab)), By Route Of Administration (Oral, Subcutaneous, Intravenous, Other Route Of Administration), By Disease Type
US$ 3,950.00
The Tnf Alpha Inhibitors Market is valued at USD 38.8 billion in 2025 and is projected to grow at a CAGR of 1.3% to reach USD 43.7 billion by 2034.The TNF Alpha Inhibitors Market plays a vital role in...
October 2025
160 pages
Tofacitinib Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Antirheumatic, Janus Kinase Inhibitor, Immunosuppressant), By Strength (5mg, 10mg, 11mg, 22mg), By Route Of Administration, By Distribution Channel, By Application
US$ 3,950.00
The Tofacitinib Market is valued at USD 4.1 billion in 2025 and is projected to grow at a CAGR of 11.8% to reach USD 11.2 billion by 2034.The Tofacitinib Market represents a dynamic segment within the...
October 2025
160 pages
Toxoplasmosis Treatment Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Pyrimethamine, Spiramycin, Leucovorin, Sulfadiazine, Folic Acid, Other Drug Class), By Indication (Chronic Toxoplasmosis Infection, Acute Toxoplasmosis Infection), By Route of Administration, By Distribution Channel
US$ 3,950.00
The Toxoplasmosis Treatment Drugs Market is valued at USD 4.3 billion in 2025 and is projected to grow at a CAGR of 6.5% to reach USD 7.6 billion by 2034.The Toxoplasmosis Treatment Drugs Market focus...
October 2025
160 pages
Tumor Necrosis Factor Inhibitor Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Humira, Enbrel, Remicade, Simponi/Simponi Aria, Cimzia, Biosimilars ), By Route Of Administration (Subcutaneous Injection, Intravenous Injection ), By Distribution Channel, By Application
US$ 3,950.00
The Tumor Necrosis Factor Inhibitor Drugs Market is valued at USD 39.2 billion in 2025 and is projected to grow at a CAGR of 2.2% to reach USD 47.7 billion by 2034.The Tumor Necrosis Factor (TNF) Inhi...
October 2025
160 pages
Global Pain and Fever Relief Drugs Market Growth 2025-2031
US$ 3,660.00
... development. Research objectives To study and analyze the global Pain and Fever Relief Drugs consumption (value & volume) by key regions ... understand the structure of Pain and Fever Relief Drugs market by identifying its various subsegments. Focuses on the key global Pain and Fever Relief Drugs manufacturers, to ...
October 2025
101 pages
Global Pediatric Drugs Market Growth 2025-2031
US$ 3,660.00
... 2017) and the growth prospects of global Pediatric Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Pediatric Drugs market by product type, application ...
October 2025
139 pages
Global Phenylephrine Hydrochloride Market Growth 2025-2031
US$ 3,660.00
... the base year being 2017) and the growth prospects of global Phenylephrine Hydrochloride market for 2018-2023. Phenylephrine Hydrochloride is an alpha-1 adrenergic agonist used as a mydriatic, nasal decongestant ...
October 2025
100 pages
Global Local Anesthesia Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Local Anesthesia Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Local Anesthesia Drugs market by product type, application ...
October 2025
103 pages
Global Bisacodyl Market Growth 2025-2031
US$ 3,660.00
... global market share (sales and revenue) of key companies in Bisacodyl business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Bisacodyl market ... breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Low Purity ...
October 2025
87 pages
Global Rivanol Market Growth 2025-2031
US$ 3,660.00
... global market share (sales and revenue) of key companies in Rivanol business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Rivanol market ... 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Rivanol Powder Rivanol Solution ...
October 2025
104 pages
Global Fexofenadine Hydrochloride Market Growth 2025-2031
US$ 3,660.00
... the global market share (sales and revenue) of key companies in Fexofenadine Hydrochloride business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Fexofenadine Hydrochloride market ...
October 2025
89 pages
Global Fexofenadine Market Growth 2025-2031
US$ 3,660.00
... global market share (sales and revenue) of key companies in Fexofenadine business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Fexofenadine market ... data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7. Purity:98% ...
October 2025
144 pages
